摘要
目的探讨慢性肾脏病流行病学合作研究(CKD-EPI)方程在中国人CKD的不同分期评估肾小球滤过率(GFR)的适用性。方法选择我院肾内科CKD患者98例。将CKl2vEPI方程估算的GFR值用体表面积(BSA)标准化得出估算GFR(eGFR),与BsA标准化的肾动态显像法(^99Tc-DTPA)检测的GFR(sGFR)用K/DOOI指南推荐的方法进行比较。结果相关性分析得出eGFR与sGFR呈正相关(r=0.847,P〈0.01);eGFR的15%、30%及50%符合率分别是31.6N、59.2%和85.7%,eGFR估计值与sGFR平均偏差2.56ml/min。CKD各期偏差均无统计学意义,在CKD2~5期,偏差较小;CKD1期,偏差略大,偏差值为(13.22±22.41),但偏差无统计学意义(P〉0.05)。结论CKD-EPI方程可广泛应用于我国CKD各期患者评估GFR,具有较小的偏差,较高的准确性。CKD-EPI方程在评估较高的GFR时,可能存在矫枉过正,高估GFR。
Objective To evaluate the applicability of the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation to estimate glomerular filtration rate in Chinese patients with CKD in different stages. Methods Ninety-eight patients with CKD were investigated. The estimated GFR (eGFR) from CKD-EPI equation-estimated GFR standardized by BSA was compared with BSA-stand- ardized sGFR measured by ^99Tc-DTPA renal dynamic imaging method. Results Correlation analysis revealed eGFR was positively correlated with sGFR (r= 0. 847, P〈0. 001). 15%, 30% and 50% coincidence rate of eGFR was 31.6%, 59. 2% and 85.7% respectively. Average deviation of eOFR from sGFR was 2. 56 (mL/min). There was no significant deviation in all stages of CKD. In the stages 2-5 of CKD, the deviations were smaller; and in the stage 1 of CKD, the deviation was slightly larger ( 13.22 ± 22. 41 ). Conclusions CKD-EPI equation can be widely used in evaluation of GFR in patients with CKD in different stages, with a less deviation, higher accuracy. When estimating GFR at higher values, it may be overcorrected or overestimated by CKD-EPI equation.
出处
《临床肾脏病杂志》
2011年第11期511-513,共3页
Journal Of Clinical Nephrology
基金
南京医科大学科技发展基金(09NJMUM066)
关键词
肾疾病
肾小球滤过率
治疗应用
Kidney disease
Glomerular filtration rate
Therapeutic uses